Article Details

Zacks Investment Research Lowers Aridis Pharmaceuticals (NASDAQ:ARDS) to Sell

Retrieved on: 2021-02-15 21:45:00

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Lowers Aridis Pharmaceuticals (NASDAQ:ARDS) to Sell. View article details on hiswai:

Excerpt

It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo